AI-augmented frameworks for enhancing Alzheimer's disease clinical trials: A memory clinic perspective

Alzheimer's disease (AD) clinical trials continue to face major hurdles in patient identification, resulting in delayed timelines, underpowered studies, and escalating costs. This perspective explores these challenges through the lens of a memory clinic, where hundreds of cases often translate into only a handful of enrollments. We highlight the potential of artificial intelligence (AI) to address this gap by powering chatbots for awareness and pre-screening, decision support tools for case identification, and algorithms for matching patients to trial-specific criteria, automating and streamlining the recruitment process. We also examine critical considerations in developing such AI-driven tools, including data standardization, privacy protections, and ethical safeguards. With thoughtful implementation, these innovations could accelerate more inclusive and efficient AD trials, ultimately bringing therapies to patients faster.